Show/hide main menu

News

News Highlights

Maurice Wohl Institute wins RIBA London Award

Posted on 06/06/2016
Wohl-RIBA-puff

Credit: Ståle Eriksen

The Maurice Wohl Clinical Neuroscience Institute at King’s College London has been honoured in this year’s prestigious RIBA London Awards for architectural excellence. 

The Institute is among 36 award-winning buildings, selected from 181 original entries and a shortlist of 68 projects. The RIBA London Award-winners will now be considered for a highly-coveted RIBA National Award to be announced on Wednesday 6 July 2016.

Christopher Shaw, Professor of Neurology and Neurogenetics at King’s and Director of the Maurice Wohl Clinical Neuroscience Institute said: ‘The Wohl is an absolute joy to work in and this award is a fitting acknowledgement of all the hard work that has gone in to making this complex project happen.

‘We were up against some really spectacular buildings, so it’s fantastic that the Institute has won a prize for its architecture, as well as its science!’

The RIBA website states: ‘The building is an inspiring precedent for scientific research where fluidity and adaptability is needed to cater for the ever-changing requirements and technologies in the field. Combining the different sub-disciplines under one roof is a bold move and the building lives up to the ambition.

‘Whilst the internal plan facilitates cross-disciplinary working, the corner cafe and the creation of high-quality public realm are key to imparting a sense of openness and transparency; bringing together researchers, clinicians and public. The building therefore reflects and enables the most exciting and human aspects of science: care, knowledge-sharing, conviviality and the joy of discovery.’

The Maurice Wohl Clinical Neuroscience Institute was officially opened by HRH The Princess Royal in June last year and is one of the leading centres for neuroscience research in the world. Bringing together more than 250 researchers and clinicians from 14 different sites across three campuses, the Institute aims to accelerate efforts to understand and develop treatments for patients affected by Alzheimer’s disease, Parkinson’s, motor neurone disease, depression, schizophrenia, epilepsy and stroke.

Rss Feed Atom Feed

News Highlights:

News Highlights...RSS FeedAtom Feed

Zebrafish reveal the ups and downs of vision

Zebrafish reveal the ups and downs of vision

Description
Researchers from the Centre for Developmental Neurobiology at King's College London have shed light on how we perceive and recognise specific visual stimuli.
Parent-led tool opens up NHS children's heart surgery data to families

Parent-led tool opens up NHS children's heart surgery data to families

Description
Researchers are calling for the end to an era of confusion and alarm about children's heart surgery statistics by launching an innovative communication tool that will help people make sense of published survival data about children's heart surgery in the UK and Ireland.
Biological factors may be involved in development of ADHD

Biological factors may be involved in development of ADHD

Description
Biological factors may be involved in the development of Attention-deficit/hyperactivity disorder (ADHD), according to new research by scientists from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London.

Share this story:

 

Follow Us

@kingscollegelon

Live Twitter feed...

@kingscollegelon
Join the conversation
Sitemap Site help Terms and conditions Privacy policy Accessibility Modern slavery statement Contact us

© 2017 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454